BioTech/Drugs - London, London, UK
Adaptate is a biotechnology company which spun-out from GammaDelta Therapeutics in 2019. Adaptate is focused on developing therapeutic antibodies to drug targets to modulate the activity of gamma delta T cells. The company has received investment from Abingworth and Takeda Pharmaceutical Company, with support from King's College London, the Francis Crick Institute and Cancer Research Technology
Outlook
Varnish
Route 53
WordPress.org
Mobile Friendly